The Breakout Curves have Spoken: $3.50 Target +31% GrowthFirst off, please don't take anything I say seriously or as financial advice. As always this is on opinion based basis. Zovio just had its breakout surge yesterday, (which I missed), but I believe it is continuing the rally. The next resistance target as a short is $3.50. If I am right, this will be an opportunity for 31%+ profit turn over in a mid risk trade.
Stocksignal
Potential 10%+ Return on ELFELF has a strong support at $15.50 with a potential to reach $18.50 for a 10%+ return within the couple weeks. Great low risk trade to take.
Possible Long Targets Set For SBBPStrongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded on May 26, 2015 and is headquartered in Lower Southampton, PA.
SHORT INTEREST
1.13M 08/15/19
Average Recommendation: BUY
Average Target Price: 13.71
P/E Current
7.53
P/E Ratio (with extraordinary items)
6.21
P/E Ratio (without extraordinary items)
6.51
ICON - RISKY But HIGH REWARDIconix Brand Group, Inc. engages in the ownership, licensing and markets a portfolio of consumer brands is a brand management company. It operates through the following segments: Women's, Men's, Entertainment, Home, and International. The company was founded in 1978 and is headquartered in New York, NY.
P/E Current
-0.10
P/E Ratio (with extraordinary items)
-0.24
SHORT INTEREST
929.86K 07/31/19
